Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study

Numerous scientific agencies and iraqi MOH has advised to promote population vaccination as an attempt to reduce the burden of COVID19. The aim of our study is to evaluate knowledge, Attitude, practice and concerns toward different type of covid19 vaccine of Iraqi population. This will help us concentrate our efforts to increase Willingness of vaccination among southren Iraqi people

Study Overview

• Status: Not yet recruiting
• Conditions: COVID-19; COVID-19 Pandemic; Sars-CoV-2 Infection

Detailed Description

Detailed Description: New human pandemic disease that have large of world population concern and have many challenges that effect on their life directly or indirectly is coronavirus infection (COVID 19).Numerous scientific agencies and iraqi MOH has advised to promote population vaccination as an attempt to reduce the burden of COVID19 so need to evalute knowledge, Attitude, practice and concerns toward different type of covid19 vaccine of iraqi population to increase willing of vaccination among southren Iraqi population to reduce mortality rate of covid19 and searching for incidence vaccination against it. So to decrease complication of covid19 pandemic, they introduced covid19 vaccine that has essential role to maintain our life. So many companies of manufacturing of covid19 vaccine with different ways by using part of viruses spike of protein or whole virus after attenuated but some Iraqi population hesitancy that delay of acceptance in spite of this vaccination is represent one of method to protect themselves from infected with covid19 in addition attended social event ,shaking hands ,leaving place when talking with other person and still wearing of mask.

Important recognition key for prevention and maintain our life is attitude judgment and how to do this to give positive or negative idea about covid19vaccine according to different source of information that concerning like social media ,experience of previous personal , governmental information and health care professional sources Considering lake of studies and research related to covid19 vaccine in Iraq ,so there is urgent need to know refused or hesitant attitude in southern Iraqi population

• Study Type: Observational
• Enrollment (Anticipated): 500

Contacts and Locations

• Study Contact: Name: Alhasan M Al-Mudhaffe, BCPS; Phone Number: +9647801601693; Email: user11126@gmail.com
• Study Contact Backup: Name: Doaa Qasim, MSc; Phone Number: 009647808071603; Email: doaaqasim2014@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Adults above 18 years old living in southern Iraq.

Description

Inclusion Criteria:

• Willingness to participate in the study
• Living in southern Iraq

Exclusion Criteria:

• Less than18 years
• Not willing to complete the questionnaire
• Unable to complete the questionnaire

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Cross-Sectional

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
survey respondant

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
KAPC knowledge, Attitude, Practice and Concerns questionnaire	How vaccination and other attitudes are affected by COVID	at the time of survey and upto 2 months

Secondary Outcome Measures

Outcome Measure	Time Frame
Factors associated with participants refusing the vaccination	at the time of survey and upto 2 months

Collaborators and Investigators

• Sponsor: AlFayhaa General Hospital
• Collaborators: University of Basra

Study record dates

Study Major Dates

• Study Start (Anticipated): March 7, 2022
• Primary Completion (Anticipated): May 1, 2022
• Study Completion (Anticipated): July 1, 2022

Study Registration Dates

• First Submitted: February 24, 2022
• First Submitted That Met QC Criteria: February 24, 2022
• First Posted (Actual): February 25, 2022

Study Record Updates

• Last Update Posted (Actual): February 25, 2022
• Last Update Submitted That Met QC Criteria: February 24, 2022
• Last Verified: February 1, 2022

More Information

Terms related to this study

• Keywords: Vaccine
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19
• Other Study ID Numbers: 20222

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Yes
• IPD Plan Description: IPD can be shared with a suitable request from other researchers
• IPD Sharing Supporting Information Type: Study Protocol; Statistical Analysis Plan (SAP)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No